Honasa Consumer Calls Off Fluence Pharma Acquisition

Honasa Consumer Ltd announced on August 25, 2026, that it has terminated the proposed acquisition of a 58% equity stake in Fluence Pharma Private Limited. The decision to call off the deal was due to the non-fulfilment of closing conditions stipulated in the Share Purchase Agreement. Despite this setback, Honasa Consumer remains committed to its nutraceutical strategy and will continue to explore both organic and inorganic opportunities to strengthen its presence in this sector.